Consultancy & Interim Management in Business Development for Life Science Industries (www.minneemanagement.com). Rob works in different roles, such as; - Strategic guidance to multi-national on health ingredients- Business development and strategy for microbiome company- Project Manager Bioriginal NBD (marketing Omega's)- Industry analyst for CDI (M&A in nutrition)- Product Development (medical food)- Consultancy for Health Strategy Consulting USA (market research)- Business Development Advisor for TNO Quality of Life (formulations)- CEO a.i. for ACS Biomarker b.v. in Maastricht (CVD)

R-Kane provides a line of meal replacement and protein products to consumers and weight loss clinics. It recently added a specialized range of supplements for Bariatric patients called 'Barisentials'. I support the development and marketing of this range.

MRM Health develops live microbial therapeutics using its proprietary Coral Technology platform to design optimized consortia of gut microbes. Rob focusses on opportunities outside of the leading pharmaceutical Rx program, such as novel probiotic strains for consumer health products.

AimFirst provides business acceleration solutions> The integrated “Lead to Revenue” process is a cloud based technology platform. See more at: www.aimfirst.com

ProDigest is the leading GI contract research provider with a range of simulations and analytical services to determine what happens in the gut. Robs helps customers determine which study fits their objectives.

BioActor bv is a health ingredient company (www.bioactor.com). From 2008 to 2011, Rob worked as Business Development Director to help build the company to first sales and to close a VC financing round. He was involved as shareholder and strategic advisor. BioActor bv develops and sells health ingredients for use in food, beverages and dietary supplements. Solabia (France) acquired a majority stake in BioActor in 2023.

Red Tree Health bv developed consumer health products such as an adventurous fruit drink based on Indian Kokum, an innovative Skin health supplement, bone health supplement and medical foods for the ketogenic diet.

Business Development of Berry polyphenols as ingredients or final consumer products (www.artemis-international.com)

Business Development and Strategy Development for TNO's research group active in novel delivery technologies for sensitive components suchs as food bioactives or pharmaceuticals.

P&L responsibility for the weight management business unit. Managed the global launch and growth of a new satiety ingredient (Fabuless™) in food and supplement applications. Led a business team with direct reports in sales and marketing and functional reports in production, R&D, finance, logistics and nutritional science. Before that as NBD Manager: Acquired new technology, set up new manufacturing partnership in Asia, evaluated new business opportunities and launched a new probiotic brand LAFTI® in the dietary supplement market. Negotiated long term global technology license and supply contract in infant formula industry (USA).

Consultant: Acquired, lead and executed projects for food, pharmaceutical and chemical industry ranging from hands-on business generation projects to long term strategic innovation consultancy.

Acquired contract research projects with external industrial partners in the food industry. Facilitated and organized the internal transition to a more professional commercial organization.